4 completed, 1 recruiting, 1 terminated, 1 withdrawn. 7 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 7 | Completed 4, Recruiting 1, Terminated 1, Withdrawn 1 |
Follow GVHD: new trials by email Literature Review of GVHD trials Research Report on GVHD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation App-based Educational Intervention - GVHD, Bone Marrow Transplant Complications | Not applicable | Recruiting | Scripps Health | 60 | 2026-04-02 | 2026-04-09 |
| In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases Blood sample taken at a single time point - Autoimmune Diseases, Inflammatory Disease | Not applicable | Completed | Assistance Publique - Hôpitaux de Paris | 67 | 2023-10-02 | 2026-02-11 |
| The Safety and Efficacy of Fecal Microbiota Transplant (FMT) for Steroid-refractory Graft-versus-host Disease Fecal Microbiota Transplant (FMT) - GVHD | Not applicable | Completed | Nanfang Hospital, Southern Medical University | 46 | 2020-04-27 | 2025-04-22 |
| Allogeneic Skin Grafting CelluTome® Epidermal Harvesting System - GVHD | Not applicable | Withdrawn | University of Minnesota | 2019-08-01 | 2021-04-20 | |
| Study of TelmisartanFor the Prevention of Acute GVHD Post Allogeneic Hematopoietic Stem Cell Transplantation Telmisartan - GVHD | Not applicable | Terminated | Hackensack Meridian Health | 32 | 2015-07-07 | 2026-04-02 |
| 70% Ethanol for Decontamination of CVL Exposed to Calcineurine Inhibitors Version 1.0, 1/9/2014 70% Ethanol - Hematopoietic Stem Cell Transplant, GVHD | Not applicable | Completed | Nationwide Children's Hospital | 13 | 2014-05-01 | 2016-01-29 |
| IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD IPL, Meibomian Gland Expression - GVHD, Ocular Rosacea | Not applicable | Completed | Mayo Clinic | 8 | 2013-10-01 | 2015-11-25 |
Alopecia (1) · Arthritis, Rheumatoid (1) · Autoimmune Diseases (1) · Dermatitis, Atopic (1) · Dry Eye Syndromes (1) · Graft vs Host Disease (1) · Inflammation (1) · Lupus Erythematosus, Systemic (1) · Multiple Sclerosis (1) · Rosacea (1) · Thyroiditis, Autoimmune (1) · Vitiligo (1)
Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Arthritis (1) · Autoimmune Diseases of the Nervous System (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Connective Tissue Diseases (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Dermatitis (1) · Endocrine System Diseases (1) · Eye Diseases (1) · Genetic Diseases, Inborn (1) · Hair Diseases (1) · Hypersensitivity (1) · Hypersensitivity, Immediate (1)
Ethanol (1) · Fecal Microbiota Transplantation (1) · Telmisartan (1)
Assistance Publique - Hôpitaux de Paris (1) · Hackensack Meridian Health (1) · Mayo Clinic (1) · Nanfang Hospital, Southern Medical University (1) · Nationwide Children's Hospital (1) · Scripps Health (1) · University of Minnesota (1)
United States (5) · China (1) · France (1)
Jake New, MD, PhD (1) · Joanne Shen, MD (1) · Scott Rowley, MD (1)